Evidence map›Paper›PMID 19906233›Full record

ReviewAnnals of the New York Academy of Sciences2009

Sex hormones and mood in the perimenopause.

Peter J Schmidt, David R Rubinow

Open access · greenAbstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 2 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 2 syntheses or guidelines pooled it, 168 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Mental health consultations during the perimenopausal age range: a qualitative study of GP and patient experiences.The British journal of general practice : the journal of the Royal College of General Practitioners · 2025
    Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Environmental Pollution to Blame for Depressive Disorder?International journal of environmental research and public health · 2022
    Article
  20. Article

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Peter J SchmidtBehavioral Endocrinology Branch, National Institute of Mental Health, Department of Health & Human Services, Bethesda, Maryland, USA. peterschmidt@mail.nih.gov
David R Rubinow
National Institute of Mental Health · CZUniversity of North Carolina at Chapel Hill · US

Funding

Psychobiology And Treatment Of Perimenopausal Mood DisordersZIAMH002537 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI SCHMIDT, PETER · 2009 to 2025
$14.9M
The Neuroregulatory Effects of Gonadal Steroids in HumansZIAMH002874 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI SCHMIDT, PETER · 2009 to 2024
$9.5M
PSYCHOBIOLOGY AND TREATMENT OF PERIMENOPAUSAL MOOD DISORDERSZ01MH002537 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI SCHMIDT, PETER J · 1990 to 2008
$1.7M
Intramural NIH HHS Z01 MH002537
6 · The paper itself

Abstract

The focus of this chapter is the relationship between the onset of depression in women and the reproductive events of the menopause transition. Epidemiologic studies have documented that the majority of women do not become depressed during the menopause transition. However, recent longitudinal studies suggest that in some women, the reproductive events related to the menopause transition could play a role in the onset of depression. No abnormality of ovarian hormones has been identified that distinguishes women with depression from those who remain asymptomatic during the menopause transition. Nonetheless, several findings suggest a role of ovarian hormones in the onset of these depressions. First, episodes of depression cluster during the stage of the menopause transition that is accompanied by estradiol withdrawal. Second, randomized controlled trials have documented the short-term (3-6 weeks) antidepressant efficacy of estradiol in depressed perimenopausal women. Third, experimentally induced estradiol withdrawal triggers mood symptoms in some women. Thus, although depression is not a uniform accompaniment of the menopause transition, in some women, age-related changes in ovarian estrogen production may alter central nervous system function and predispose them to develop depression.

Indexed as

DepressionEstrogen Replacement TherapyPerimenopauseCross-Sectional StudiesEstrogensFemaleHumansLongitudinal StudiesMiddle AgedRandomized Controlled Trials as TopicTime FactorsEstrogens

Identifiers

PMID19906233
PMCPMC2891531
OpenAlexW2083857481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.